{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:23:30Z","timestamp":1774959810684,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>PET is a useful tool for detecting the presence and extent of brain tau accumulation. However, most first-generation tau PET tracers are limited for high off-target binding and detection of tau in non-Alzheimer disease (AD). This study evaluated potential clinical applications of <jats:sup>18<\/jats:sup>F-PI-2620 as a novel PET tracer with a high binding affinity for tau deposition in AD and non-AD tauopathies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Twenty-six participants diagnosed with either mild cognitive impairment, probable AD, frontotemporal dementia, or parkinsonism, as well as healthy controls underwent a 60- to 90-minute brain PET scan after 7 mci (259 MBq) injection of <jats:sup>18<\/jats:sup>F-PI-2620. Some participants had previous PET scans using <jats:sup>18<\/jats:sup>F-THK-5351 or <jats:sup>18<\/jats:sup>F-FP-CIT for dopamine transporter imaging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All participants showed no increase in off-target binding in basal ganglia on <jats:sup>18<\/jats:sup>F-PI-2620 PET images, as noted for first-generation tau tracers. A\u03b2+ mild cognitive impairment or AD patients showed diverse cortical <jats:sup>18<\/jats:sup>F-PI-2620 uptake in frontotemporoparietal cortex that correlated with Mini-Mental Status Examination (\u03c1 = \u22120.692, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.013). A\u03b2+ Parkinson disease with dementia and (A\u03b2 unknown) primary progressive aphasia patients also showed increased <jats:sup>18<\/jats:sup>F-PI-2620 uptakes in the frontotemporoparietal cortex. Patients with parkinsonism showed increased uptakes in the pallidum compared with A\u03b2\u2212 healthy controls (left: 1.41 \u00b1 0.14 vs 1.04 \u00b1 0.13, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.014; right: 1.18 \u00b1 0.16 vs 0.95 \u00b1 0.07, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.014).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-PI-2620 PET might be a sensitive tool to detect cortical tau deposits in patients with A\u03b2+ AD and A\u03b2+ non-AD tauopathies. Furthermore, this study showed that \u201coff-target\u201d binding in the basal ganglia does not affect <jats:sup>18<\/jats:sup>F-PI-2620.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003261","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:25:00Z","timestamp":1601501100000},"page":"841-847","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351"],"prefix":"10.1097","volume":"45","author":[{"given":"Minyoung","family":"Oh","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Jun","family":"Oh","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Ju","family":"Lee","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungsu S.","family":"Oh","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hoon","family":"Roh","sequence":"additional","affiliation":[{"name":"Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[{"name":"Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hong","family":"Lee","sequence":"additional","affiliation":[{"name":"Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong Sik","family":"Lee","sequence":"additional","affiliation":[{"name":"Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Kim","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer's disease facts and figures","volume":"14","year":"2018","journal-title":"Alzheimers Dement"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","year":"2003","journal-title":"Neurology"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13311-016-0490-y","article-title":"Tau imaging in Alzheimer's disease diagnosis and clinical trials","volume":"14","year":"2017","journal-title":"Neurotherapeutics"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2967\/jnumed.119.236240","article-title":"Evaluation of dosimetry, quantitative methods and test-retest variability of (18)F-PI-2620 PET for the assessment of tau deposits in the human brain","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"bib8-20230925","first-page":"65","article-title":"Aging, memory, and mild cognitive impairment","volume":"9","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","year":"2011","journal-title":"Brain"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","year":"2011","journal-title":"Neurology"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","year":"1996","journal-title":"Neurology"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","year":"2017","journal-title":"Neurology"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00259-018-4125-x","article-title":"Differences in gray and white matter 18 F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jlcr.3115","article-title":"Development of a new precursor-minimizing base control method and its application for the automated synthesis and SPE purification of [18F] fluoromisonidazole ([18F] FMISO)","volume":"56","year":"2013","journal-title":"J Label Compd Radiopharm"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","year":"2002","journal-title":"Neuron"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","year":"1995","journal-title":"Neurobiol Aging"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","year":"2016","journal-title":"Brain"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","volume":"157","year":"2017","journal-title":"Neuroimage"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11682-018-9847-7","article-title":"PET imaging of tau protein targets: a methodology perspective","volume":"13","year":"2019","journal-title":"Brain Imaging Behav"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awy049","article-title":"FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis","volume":"141","year":"2018","journal-title":"Brain"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mdc3.12584","article-title":"Tau imaging in parkinsonism: what have we learned so far?","volume":"5","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"bib25-20230925","first-page":"P128","article-title":"18F-PI2620 tau-PET in progressive supranuclear palsy: a multi-center evaluation","volume":"15","year":"2019","journal-title":"Alzheimers Dement"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/brain\/awm104","article-title":"Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome","volume":"130","year":"2007","journal-title":"Brain"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","year":"2015","journal-title":"Ann Neurol"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00259-019-04305-8","article-title":"Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.25183","article-title":"[(18) F]AV-1451 tau-PET and primary progressive aphasia","volume":"83","year":"2018","journal-title":"Ann Neurol"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review","volume":"82","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12149-019-01344-x","article-title":"Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site","volume":"33","year":"2019","journal-title":"Ann Nucl Med"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.24706","article-title":"[F-18]AV-1451 positron emission tomography retention in choroid plexus: more than \u201coff-target\u201d binding","volume":"80","year":"2016","journal-title":"Ann Neurol"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.dadm.2018.01.007","article-title":"Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding","volume":"10","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12149-017-1205-0","article-title":"Uptake of AV-1451 in meningiomas","volume":"31","year":"2017","journal-title":"Ann Nucl Med"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2967\/jnumed.118.209916","article-title":"Characterization of 3 novel tau radiopharmaceuticals, (11)C-RO-963, (11)C-RO-643, and (18)F-RO-948, in healthy controls and in Alzheimer subjects","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib37-20230925","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-001-0488-2","article-title":"Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration","volume":"103","year":"2002","journal-title":"Acta Neuropathol"},{"key":"bib38-20230925","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.111.095224","article-title":"Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy","volume":"53","year":"2012","journal-title":"J Nucl Med"},{"key":"bib39-20230925","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jamaneurol.2016.3243","article-title":"Subregional pattern of striatal dopamine transporter loss on 18F FP-CIT positron emission tomography in patients with pure akinesia with gait freezing","volume":"73","year":"2016","journal-title":"JAMA Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:18:23Z","timestamp":1695622703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003261","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,9]]}}}